Immunogen - immunogen.com : ImmunoGen, Inc.: Home

Learn more about Immunogen's ADC technology used in Roche's KadcylaÂ®, changing the lives of people with cancer.

2.33 Rating by ClearWebStats

immunogen.com is 2 decades 7 years 2 weeks old. This website has a #1,152,291 rank in global traffic. It has a .com as an domain extension. This website has a Google PageRank of 4 out of 10. This domain is estimated value of $ 720.00 and has a daily earning of $ 3.00. While no active threats were reported recently by users, immunogen.com is SAFE to browse.

Updated 8 years 10 months ago

Get Custom Widget

Traffic Report of Immunogen

Daily Unique Visitors:	418
Daily Pageviews:	836

Estimated Valuation

Income Per Day:	$ 3.00
Estimated Worth:	$ 720.00

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	Not Applicable

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Good
WOT Privacy:	Good
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:
Alexa Rank:	1,152,291
Domain Authority:	Not Applicable

Google Pagerank

PR 4 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is immunogen.com server located?

Hosted IP Address:

173.203.62.111

View other site hosted with immunogen.com

Hosted Country:

Location Latitude:

41.85

Location Longitude:

-87.65

Social Engagement

Facebook Shares:	Not Applicable
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	2
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

Homepage Links Analysis

View immunogen.com homepage link analysis

Page Title of Immunogen

ImmunoGen, Inc.: Home

Meta Tags of Immunogen

immunogen, adc technology, roche kadcyla, immunogen drug, antibody drug conjugates, metastatic bladder cancer drugs, anticancer product, tumor targeting antibody, immunogen adc, adc kadcyla, immunogen cancer, immunogen treatment, immunogen inc, metastatic breast cancer treatment

Website Inpage Analysis

H1 Headings:	Not Applicable	H2 Headings:	3
H3 Headings:	Not Applicable	H4 Headings:	Not Applicable
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	Not Applicable	Total Images:	19
Google Adsense:	Not Applicable	Google Analytics:	UA-22837708-1

Websites Hosted on Same IP (i.e. 173.203.62.111)

Array BioPharma :: Home

- arraybiopharma.com

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

1,389,310

$ 480.00

Cepheid | Cepheid - Delivering timely diagnostic information when it matters most.

- cepheid.com

Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. The advantages over other technologies are accuracy, speed, and ease-of-use — quickly getting important information into the hands of healthcare professionals to dramatically improve patient outcomes.

1,058,008

$ 720.00

Achillion Pharmaceuticals: Home

- achillion.com

Headquartered in New Haven, CT, Achillion is a leading-edge pharmaceutical company advancing multiple candidates with proven mechanisms for the treatment of HCV and a novel complement factor D inhibitor platform. Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Complement-related diseases comprise a significant market opportunity.

1,059,313

$ 720.00

Theravance Biopharma.: Home

- theravance.com

Theravance Biopharma is a biopharmaceutical company with one approved product, VIBATIV® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

1,170,231

$ 720.00

InSite Vision Incorporated - Home

- insitevision.com

InSite Vision develops products to treat a growing range of common eye problems: ocular infection, pain & inflammation in ocular surgery and glaucoma. Learn more

3,231,460

$ 240.00

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Server: Apache
Vary: Accept-Encoding
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Content-Type: text/html; charset=ISO-8859-1
Content-Encoding: gzip
Date: Wed, 10 Jun 2015 18:25:06 GMT
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Pragma: no-cache
Content-Length: 9603

Domain Information for immunogen.com

Domain Registrar:	NETWORK SOLUTIONS, LLC.
Registration Date:	1997-04-04 2 decades 7 years 2 weeks ago
Last Modified:	2012-12-14 1 decade 1 year 4 months ago
Expiration Date:	2018-04-05 6 years 2 weeks 4 days ago

Domain Nameserver Information

Host		IP Address	Country
ns47.worldnic.com		162.159.26.111	Unknown or Invalid Region
ns48.worldnic.com		162.159.27.50	Unknown or Invalid Region

DNS Record Analysis

Host	Type	TTL	Extra
immunogen.com	A	7198	IP:173.203.62.111
immunogen.com	NS	7199	Target:ns47.worldnic.com
immunogen.com	NS	7199	Target:ns48.worldnic.com
immunogen.com	SOA	7199	MNAME:NS47.WORLDNIC.com RNAME:namehost.WORLDNIC.com Serial:115010514 Refresh:10800 Retry:3600 Expire:604800
immunogen.com	MX	5031	Priority:15 Target:imgnsmtp2.immunogen.com
immunogen.com	MX	5031	Priority:10 Target:imgnsmtp.immunogen.com
immunogen.com	TXT	7199	TXT:v=spf1 a mx ip4:65.217.159.215 ~all